Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.
Try Elite for Free
Last Close
20.62
Nov 06 • 3:59 PM ET Dollar change+0.35 Percentage change(1.73%)
Aftermarket Close
20.62
Aftermarket • 5:23 PM ET Dollar change0.00 Percentage change(0.00%)
Nov 04, 6:42 PMProcept BioRobotics Q3 2026 revenue $98.3M (+18% YoY) misses estimates, maintains 2026 outlook and targets Q4 positive EBITDA
Index
RUT
Market Cap
1.19B
Enterprise Value
1.05B
Income
-114.86M
Sales
352.30M
Book/sh
5.73
Cash/sh
3.80
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
888
IPO
Sep 15, 2021
P/E
-
Forward P/E
-
PEG
-
P/S
3.37
P/B
3.60
P/C
5.43
P/FCF
-
EV/EBITDA
-
EV/Sales
2.97
Quick Ratio
4.72
Current Ratio
5.88
Debt/Eq
0.23
LT Debt/Eq
0.23
Option/Short
Yes / Yes
EPS (ttm)
-2.03
EPS next Y
-1.22
EPS next Q
-0.23
EPS this Y
0.11%
EPS next Y
28.98%
EPS next 5Y
20.70%
EPS past 3/5Y
4.30% -7.02%
Sales past 3/5Y
60.14% 109.04%
EPS Y/Y TTM
-25.05%
Sales Y/Y TTM
17.47%
EPS Q/Q
-20.41%
Sales Q/Q
17.96%
Insider Own
4.63%
Insider Trans
0.83%
Inst Own
95.33%
Inst Trans
-5.87%
ROA
-23.31%
ROE
-32.39%
ROIC
-28.48%
Gross Margin
64.66%
Oper. Margin
-33.61%
Profit Margin
-32.60%
SMA20
6.08%
SMA50
6.73%
SMA200
-10.61%
Trades
Shs Outstand
57.44M
Shs Float
54.62M
52W High
38.11 -45.89%
52W Low
16.67 23.73%
Volatility
10.24% 6.44%
ATR (14)
1.37
RSI (14)
56.50
Beta
0.81
Rel Volume
1.35
Avg Volume
1.27M
Volume
1,715,447
Perf Week
7.40%
Perf Month
15.20%
Perf Quarter
-5.02%
Perf Half Y
-18.82%
Perf YTD
-34.46%
Perf Year
-34.12%
Perf 3Y
-37.17%
Perf 5Y
-52.05%
Perf 10Y
-
Prev Close
20.27
Price
20.62
Change %
1.73%
Consensus
Buy
Avg. Price Target
$22.75
Implied Upside
+10.3%
Analysts15incl. previous ratings
Rating Distribution5 Buy · 9 Hold · 1 Sell
DateActionAnalystRating ChangePrice Target ChangeImplied Upside
Oct 07, 2026Initiated
BCS logoBBarclays
Overweight$30+45.5%
Aug 05, 2026Downgrade
WWilliam Blair
Outperform → Mkt Perform
Aug 05, 2026Downgrade
WFC logoWWells Fargo
Overweight → Equal Weight$19-7.9%
Jul 28, 2026Downgrade
UBS logoUUBS
Buy → Neutral$20-3.0%
Jul 06, 2026Downgrade
TFC logoTTruist
Buy → Hold$25+21.2%
Jun 24, 2026Initiated
EVR logoEEvercore ISI
Outperform$30+45.5%
Jun 11, 2026Downgrade
LLeerink Partners
Outperform → Market Perform$29+40.6%
Mar 06, 2026Initiated
RRobert W. Baird
Neutral$30+45.5%
Feb 26, 2026Downgrade
OPY logoOOppenheimer
Outperform → Perform
Feb 26, 2026Downgrade
BAC logoBBofA Securities
Neutral → Underperform$20-3.0%
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Sharma PoojaOfficerNov 06 '26Proposed Sale19.714,71092,853Nov 06 03:21 PM
Nouri AlalehEVP, CLO, CORP. SEC.Sep 09 '26Sale20.952976,223127,737Sep 10 04:45 PM
Templin Barry LEVP, Chief Technology OfficerSep 09 '26Sale20.953737,81594,826Sep 10 04:44 PM
Waters KevinEVP, CFOSep 09 '26Sale20.953737,815180,355Sep 10 04:42 PM
Nouri AlalehOfficerSep 09 '26Proposed Sale20.952976,223Sep 09 03:15 PM
Templin Barry LOfficerSep 09 '26Proposed Sale20.953737,816Sep 09 03:14 PM
Waters KevinOfficerSep 09 '26Proposed Sale20.953737,816Sep 09 03:12 PM
Wood Larry LPresident, CEOAug 07 '26Buy20.8523,900498,31523,900Aug 10 06:07 AM
Nouri AlalehEVP, CLO, CORP. SEC.Jun 08 '26Sale28.482858,117105,069Jun 10 04:21 PM
Waters KevinEVP, CFOJun 08 '26Sale28.4835710,167151,201Jun 10 04:18 PM
Templin Barry LEVP, Chief Technology OfficerJun 08 '26Sale28.4835810,19568,953Jun 10 04:15 PM
Nouri AlalehOfficerJun 08 '26Proposed Sale28.482858,117Jun 08 04:34 PM
Waters KevinOfficerJun 08 '26Proposed Sale28.4835710,167Jun 08 04:09 PM
Templin Barry LOfficerJun 08 '26Proposed Sale28.4835810,195Jun 08 03:26 PM
Nouri AlalehEVP, CLO, CORP. SEC.Mar 19 '26Sale25.965,363139,231105,354Mar 19 05:47 PM
Alalah NouriOfficerMar 19 '26Proposed Sale26.175,363140,349Mar 19 04:57 PM
Nouri AlalehEVP, CLO, CORP. SEC.Mar 17 '26Sale28.153048,559110,717Mar 19 04:25 PM
Waters KevinEVP, CFOMar 17 '26Sale28.1570619,876151,558Mar 19 04:25 PM
Nouri AlalehOfficerMar 17 '26Proposed Sale28.153048,559Mar 17 03:14 PM
Waters KevinOfficerMar 17 '26Proposed Sale28.1570619,876Mar 17 03:13 PM
Nouri AlalehEVP, CLO, CORP. SEC.Mar 10 '26Sale25.653,24383,197111,021Mar 12 04:02 PM
Alalah NouriOfficerMar 10 '26Proposed Sale25.263,24381,918Mar 10 04:04 PM
Desai Antal RohitDirectorMar 05 '26Buy25.58167,2464,278,549167,246Mar 09 07:19 PM
Desai Antal RohitDirectorMar 06 '26Buy23.59160,3173,781,503327,563Mar 09 07:19 PM
Desai Antal RohitDirectorMar 09 '26Buy24.5598,6992,422,891426,262Mar 09 07:19 PM
Nouri AlalehEVP, CLO, CORP. SEC.Mar 06 '26Sale23.706,892163,353114,264Mar 09 05:43 PM
Waters KevinEVP, CFOMar 06 '26Sale23.706,721159,300152,264Mar 09 05:40 PM
Nouri AlalehOfficerMar 06 '26Proposed Sale23.706,892163,353Mar 06 04:19 PM
Waters KevinOfficerMar 06 '26Proposed Sale23.706,721159,300Mar 06 04:07 PM
PROCEPT BioRobotics Corp. is a commercial-stage surgical robotics company, which engages in the development of transformative solutions in urology. It manufactures and sells the AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery, with an initial focus on treating BPH. The firm's proprietary AquaBeam Robotic System employs a single-use disposable handpiece to deliver its Aquablation therapy, which combines real-time, multidimensional imaging, personalized treatment planning, automated robotics and heat-free waterjet ablation for targeted and rapid removal of prostate tissue. The company was founded by Nikolai Aljuri and Rodney C. Perkins in 2007 and is headquartered in San Jose, CA.
PresidentMr. Larry L. Wood
Executive VP & CFOMr. Kevin Waters
EVPMs. Alaleh Nouri
Executive Vice President of OperationsMr. Christofer Christoforou
Executive VP & CTOMr. Barry Templin